Your weekly roundup of the latest news from Drug Topics®.
Pfizer-BioNTech hopes booster can be available for use this fall.
Domestic production to begin at Michigan-based pharmaceutical maker.
Consumers are purchasing dietary supplements that support or boost the immune system like never before.
The vaccine was previously authorized under an EUA for adults aged 18 and older.
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.